Living Well is a CE certified class I medical device. It is a comprehensive programme to support patients mental health post-cancer diagnosis and during treatment.

‍

The tool helps them deal with challenging emotions and immense stress through a friendly and easily accessible application.The aim is to reduce their stress level, regain control over their own well-being and build healthy habits.

Prosoma leads at the forefront of digital therapeutics for oncology. We’re digital therapeutics innovators reinventing healthcare. Finding new solutions that improve existing and emerging challenges in the field. At Prosoma, we believe that breakthrough digital health innovations are not meant for the future but rather the present. The whole world around us has changed and is constantly changing with technology. We can manage our entire lives through the many devices we’re constantly surrounded with. Everything has become more accessible, progressive and available at our fingertips. Why should healthcare be any different? We believe in a world where innovation pushes the care pathway forward, enabling and empowering patients, doctors and therapists. We are an interdisciplinary team of scientists, engineers and psychologists. We provide patients with comprehensive solutions fully tailored to their specific conditions. Our applications are created by combining world-leading expertise in medicine and technology. We use the latest developments in artificial intelligence and new opportunities offered by mobile technology. We aim to help patients manage unpleasant situations, create healthy habits, and support them through their recovery process.

Moovcare® is a medical application that needs to be prescribed by your oncologist and helps you stay connected to your medical team. If your physician determines that you are eligible to be included into Moovcare® platform, you will start receiving a digital questionnaire once a week, which you can answer via your smartphone, laptop or tablet.

You will be required to self report your symptoms, Moovcare® algorithm will analyse your answers and if it detects an anomaly or complication, an immediate notification will be sent to your treating physician. Moovcare is a digital therapeutic that uses a simple questionnaire to detect relapse or complications during follow-up of lung cancer patients. It enables monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly. It was founded in 2014 and is based in Jerusalem, Israel.

We are a multidisciplinary team of clinicians, technologists, and behavioral experts united to tackle some of the most significant challenges in healthcare.

Drawing on multi-year clinical studies conducted by leading oncologists in the US and France, we have developed the first digital platform for the early detection of diseases. These studies highlight the impact of patient-reported symptoms on survival and quality of life, forming the foundation of our innovative approach.

Living Well is a class I medical device in accordance with the Council Directive 93/42/EEC, on medical devices (MDD). The certification ensures adherance with highest European standards. Living Well has been developed by world-renowned experts in the fields of psycho-oncology, CBT, user experience, data science, and of course the patients themselves.

Moovcare® was proven in a clinical study to significantly improve lung cancer patients’ well being, as well as the communication with the medical team.